-+ 0.00%
-+ 0.00%
-+ 0.00%

HBM Healthcare Investments Set to Receive Payments from Portfolio Company Sale

MT Newswires·12/08/2025 10:31:28
Listen to the news
10:31 AM EST, 12/08/2025 (MT Newswires) -- HBM Healthcare Investments (HBMNE.SW) is set to receive $6 million in cash and $7 million in Mirum Pharmaceuticals (08D.F, 08D.BE) shares upon completion of the sale of its portfolio company Bluejay Therapeutics to the US-based biopharmaceutical company. The Swiss healthcare investment group said Monday that Bluejay Therapeutics agreed to be acquired by Mirum in a cash-and-stock deal worth up to $820 million, including potential sales-based milestones. As such, HBM also anticipates additional milestone-based payments of up to $3.7 million from Bluejay's sale.